These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 146053)
1. Cytotoxic activity of lymphocytes. VII. cellular origin of alpha-lymphotoxin. Yano K; Lucas ZJ J Immunol; 1978 Feb; 120(2):385-94. PubMed ID: 146053 [TBL] [Abstract][Full Text] [Related]
2. Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production. Woody JN; Ahmed A; Knudsen RC; Strong DM; Sell KW J Clin Invest; 1975 May; 55(5):956-66. PubMed ID: 1091657 [TBL] [Abstract][Full Text] [Related]
3. Lymphotoxin and chemotactic factor produced in vitro by human lymphocytes during their proliferative response in the presence of phytohaemagglutinin and Nocardia water-soluble mitogen. Prieur AM; Pham Huu T Ann Immunol (Paris); 1980; 131D(2):223-32. PubMed ID: 6970542 [TBL] [Abstract][Full Text] [Related]
4. Human T cell hybridomas producing cytotoxic lymphokines: induction of lymphotoxin release and killer cell activity by anti-CD3 monoclonal antibody or lectins and phorbol ester. Ware CF; Green LM; Reade J; Stern ML; Berger AE Lymphokine Res; 1986; 5(4):313-24. PubMed ID: 2878123 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin. Green LM; Reade JL; Ware CF; Devlin PE; Liang CM; Devlin JJ J Immunol; 1986 Dec; 137(11):3488-93. PubMed ID: 2431035 [TBL] [Abstract][Full Text] [Related]
6. The human LT system. XI. Identification of LT and "TNF-like" forms from stimulated natural killers, specific and nonspecific cytotoxic human T cells in vitro. Yamamoto RS; Ware CF; Granger GA J Immunol; 1986 Sep; 137(6):1878-84. PubMed ID: 2943806 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxic activity of lymphocytes. VI. Heterogeneity of cytotoxins in supernatants of mitogen-activated lymphocytes. Walker SM; Lee SC; Lucas ZJ J Immunol; 1976 Mar; 116(3):807-15. PubMed ID: 1082895 [TBL] [Abstract][Full Text] [Related]
8. Production of lymphotoxin and tumour necrosis factor by a T-cell hybridoma. Kobayashi Y; Asada M; Osawa T Immunology; 1987 Feb; 60(2):213-7. PubMed ID: 3102354 [TBL] [Abstract][Full Text] [Related]
9. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. Ware CF; Crowe PD; Grayson MH; Androlewicz MJ; Browning JL J Immunol; 1992 Dec; 149(12):3881-8. PubMed ID: 1281193 [TBL] [Abstract][Full Text] [Related]
10. Lymphotoxin production in multiple sclerosis patients. Głabiński A; Pokoca L; Tchórzewski H; Selmaj K Arch Immunol Ther Exp (Warsz); 1991; 39(3):285-90. PubMed ID: 1810221 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of human peripheral blood lymphocytes by periodate, galactose oxidase, soybean agglutinin, and peanut agglutinin: differential effects of adherent cells. Novogrodsky A; Stenzel KH; Rubin AL J Immunol; 1977 Mar; 118(3):852-7. PubMed ID: 191527 [TBL] [Abstract][Full Text] [Related]
12. Production of lymphotoxin, IFN-gamma and IFN-alpha, beta by murine T cell lines and clones. Conta BS; Powell MB; Ruddle NH J Immunol; 1983 May; 130(5):2231-5. PubMed ID: 6403618 [TBL] [Abstract][Full Text] [Related]
13. In vitro response of subpopulations of human tonsil lymphocytes. I. Cellular collaboration in the proliferative response to PHA and Con A. Delespesse G; Duchateau J; Gausset P; Govaerts A J Immunol; 1976 Feb; 116(2):437-45. PubMed ID: 1082457 [TBL] [Abstract][Full Text] [Related]
14. Interaction of plant lectins with purified human lymphocyte populations: binding characteristics and kinetics of proliferation. Boldt DH; MacDermott RP; Jorolan EP J Immunol; 1975 May; 114(5):1532-6. PubMed ID: 1079038 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3. Steffen M; Ottmann OG; Moore MA J Immunol; 1988 Apr; 140(8):2621-4. PubMed ID: 3258616 [TBL] [Abstract][Full Text] [Related]
16. Kinetic study of T lymphocytes after sensitization against soluble antigen. I. Separation on density gradients. Durkin HG; Waksman BH J Immunol; 1975 Jul; 115(1):170-6. PubMed ID: 1097501 [TBL] [Abstract][Full Text] [Related]
17. The role of lymphotoxin in target cell destruction induced by mitogen-activated human lymphocytes in vitro. II. The correlation of temperature and trypsin-sensitive phases of lymphotoxin-induced and lymphocyte-mediated cytotoxicity. Kramer SL; Granger GA J Immunol; 1976 Feb; 116(2):562-7. PubMed ID: 1082459 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of human lymphocyte-mediated mitogen-induced cytotoxicity of murine L-929 cells by heterologous anti-human lymphotoxin antisera in vitro. Hiserodt JC; Granger GA J Immunol; 1977 Aug; 119(2):374-80. PubMed ID: 301888 [TBL] [Abstract][Full Text] [Related]
19. Production of osteoclast-activating factor by normal human peripheral blood rosetting and nonrosetting lymphocytes. Chen P; Trummel C; Horton J; Baker JJ; Oppenheim JJ Eur J Immunol; 1976 Oct; 6(10):732-6. PubMed ID: 797286 [TBL] [Abstract][Full Text] [Related]
20. Immunoregulatory functions of cultured human T lymphocytes. Uchiyama T; Broder S; Bonnard GD; Waldmann TA Trans Assoc Am Physicians; 1980; 93():251-62. PubMed ID: 6264658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]